We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Batm Advanced Communications Ld | LSE:BVC | London | Ordinary Share | IL0010849045 | ORD ILS0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.20 | -0.96% | 20.60 | 20.00 | 20.60 | 20.60 | 19.80 | 19.95 | 346,632 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Communications Services, Nec | 122.83M | -193k | -0.0004 | -500.00 | 90.7M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/5/2020 07:23 | Nothing new in that, other than there is competition already out there for antibody lab testing.Hinted that home diagnostic kit for cold, flu and covid 19 coming along. | paulisi | |
05/5/2020 23:29 | Working on a common cold, flu and Covid test. | northwards | |
05/5/2020 23:04 | Marom Interview re new kits you will have to cut and paste www.proactiveinvesto Here is a link to Adaltis microELISA units | fse | |
05/5/2020 15:56 | BATM are becoming a power house in the infectious diseases department and the scope and value of their IP is getting demonstrated once again. This test is on the Elisa platform something the company has considerable existing experience with. I was not aware they Adaltis were developing an antibody test but they always had the credentials to. I was not aware celitron were going to produce ventilators but they had the capacity to do this. The capability and capacity of this company to innovate is very apparent and they are sitting on some very valuable IP. These 2 recent announcements are on top of what the company is working on. The relevance of having a "reliable" antibody test is a timeline management tool that can be used for Covid19 and any other infectious disease variant we encounter. If we had this type of test at the outset we might have saved ourselves a multi trillion $ screw up. | fse | |
05/5/2020 12:16 | 'If its inflation then you don't really want to be left holding cash'Yes and that's why equities are defying reality.Money has to find a home.However,there are clears winners in healthcare and high tech.Stray heavily out of those parameters and you might well get stung.I feel the bottom fishing that has seen the likes of construction etc recover from recent lows has now largely been completed and could give way to an unfolding harsh reality that could such sectors retrace.As for BATM,it appears to tick the right boxes.A stock I held over twenty years ago. | steeplejack | |
05/5/2020 11:16 | I bought these fairly recently - has been one of my better deals (also bought RPS recently which went up 50% in a month). Have had my share of disasters too - Lloyds, Aviva. I'm £75k down this year, which is significant. That is £50k off the low point, so I guess things have been worse. I'm not sure which way the market will go from here - choppy is the only certainty. I don't think anyone knows how much damage has been done, and where the money that has been created will end up. If its inflation then you don't really want to be left holding cash. | dr biotech | |
05/5/2020 10:50 | Nellyb I do ok. Been tough recently obvs | volsung | |
05/5/2020 10:45 | volsung, you buy/sell regularly. I presume you must do well on some shares! | nellyb | |
05/5/2020 10:30 | This is the key part of the statementThe two kits include Adaltis' diagnostic tests that are being shipped for medical facility use and the kits that the Group is developing in partnership with Novamed for home use.The lab tests are quite common.The home kits will be the big earner for those who have approval and are first to the market. | paulisi | |
05/5/2020 09:58 | Ok can’t believe I’m buying these again at 69p when not too long ago I sold at under 40p. Oh well | volsung | |
05/5/2020 09:57 | Zvi normally appears on proactive investors after an announcement. | paulisi | |
05/5/2020 09:20 | Might be another surge when US opens up this afternoon. | rawdeal1 | |
05/5/2020 09:18 | Rob1ng ... wondering the same. Perhaps all share holders can get free kits. I had similar illness back in Jan. Anyway, I've held for long enough... another couple of years ain't gonna harm. In fact could be very very profitable. | rawdeal1 | |
05/5/2020 08:51 | Agreed, this is a solid buy and hold especially in the current economic climate. This and BUR, 2 top buys.The ceo did warn us he got a few more aces up his sleeve :-)BVC just had a quick mention on cnbc , more to come here. | 2toptrader | |
05/5/2020 08:51 | Same here although I did top up in March at 44p. Strong hold this now. | blueflame | |
05/5/2020 08:50 | Good news,I was here before the 10/1share split as well.I wonder if I can get kit to confirm it was covid 19 that nearly killed me 2.5 months ago ,not bad enough to be hospitalised but frightening enough tho | rob1ng | |
05/5/2020 08:37 | Been here for 15+ years. The rabbit has finally been pulled from the hat. Yehaaaa!!! | rawdeal1 | |
05/5/2020 08:32 | been here for 10 years - sounds like some have been here for 10 days! | nellyb | |
05/5/2020 08:27 | Zvi talked about a few more surprises.There is one.Expect a follow up order for ventilators as well.Antibody tests, home kits.This is a long term hold.Definitely see the two divisions splitting and a special dividend next year.There was also mention of some bolt on purchases to come in the annual reports. | paulisi | |
05/5/2020 08:16 | thank you, it was a pleasure doing business here :) | rumobejo | |
05/5/2020 08:16 | awesome news - antibody test and already selling into Europe...more to come here, demand could be huge. | pre | |
05/5/2020 08:13 | 72p and rising.Do I sell a percentage of hang on for the ride? | paulisi | |
05/5/2020 08:11 | Lovely what do I do now? | red5 | |
05/5/2020 08:08 | woooosh :) | thelongandtheshortandthetall | |
05/5/2020 08:08 | Rather pleasant surprise | money4me |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions